Glaukos Corporation

Symbol: GKOS

NYSE

107.62

USD

Market price today

  • -37.8767

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 5.42B

    MRK Cap

  • 0.00%

    DIV Yield

Glaukos Corporation (GKOS) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.76%

Operating Profit Margin

-0.38%

Net Profit Margin

-0.43%

Return on Assets

-0.15%

Return on Equity

-0.30%

Return on Capital Employed

-0.14%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Devices
CEO:Mr. Thomas William Burns
Full-time employees:907
City:San Clemente
Address:229 Avenida Fabricante
IPO:2015-06-25
CIK:0001192448

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite, a three stents product that is designed for use as a standalone procedure in patients with refractory glaucoma; and iDose TR, a targeted injectable implant based on its micro-scale device-platform that is designed to deliver therapeutic levels of medication. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in San Clemente, California.

General Outlook

When we look at how much money they make before expenses, they keep 0.762% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.377%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.432%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.151% return, is a testament to Glaukos Corporation's adeptness in optimizing resource deployment. Glaukos Corporation's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.300%. Furthermore, the proficiency of Glaukos Corporation in capital utilization is underscored by a remarkable -0.143% return on capital employed.

Stock Prices

Glaukos Corporation's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $102.95, while its low point bottomed out at $95.39. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Glaukos Corporation's stock market.

Liquidity Ratios

Analyzing GKOS liquidity ratios reveals its financial health of the firm. The current ratio of 537.96% gauges short-term asset coverage for liabilities. The quick ratio (442.16%) assesses immediate liquidity, while the cash ratio (58.83%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio537.96%
Quick Ratio442.16%
Cash Ratio58.83%

Profitability Ratios

GKOS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -42.88% underscores its earnings before tax deductions. The effective tax rate stands at -0.65%, revealing its tax efficiency. The net income per EBT, 100.65%, and the EBT per EBIT, 113.75%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -37.69%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-42.88%
Effective Tax Rate-0.65%
Net Income per EBT100.65%
EBT per EBIT113.75%
EBIT per Revenue-37.69%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 5.38, it details the span from stock purchase to revenue. The 4 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 701.33% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding442
Days of Inventory Outstanding236
Operating Cycle287.60
Days of Payables Outstanding60
Cash Conversion Cycle228
Receivables Turnover7.01
Payables Turnover6.10
Inventory Turnover1.55
Fixed Asset Turnover1.90
Asset Turnover0.35

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -1.23, and free cash flow per share, -1.52, depict cash generation on a per-share basis. The cash per share value, 5.50, showcases liquidity position. Lastly, the operating cash flow sales ratio, -0.19, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-1.23
Free Cash Flow per Share-1.52
Cash per Share5.50
Operating Cash Flow Sales Ratio-0.19
Free Cash Flow to Operating Cash Flow Ratio1.24
Cash Flow Coverage Ratio-0.21
Capital Expenditure Coverage Ratio-4.25
Dividend Paid and Capex Coverage Ratio-4.25

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 30.33%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.63, we discern the balance between debt and equity financing. The long-term debt to capitalization, 38.58%, and total debt to capitalization, 38.58%, ratios shed light on its capital structure. An interest coverage of -9.00 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio30.33%
Debt Equity Ratio0.63
Long Term Debt to Capitalization38.58%
Total Debt to Capitalization38.58%
Interest Coverage-9.00
Cash Flow to Debt Ratio-0.21
Company Equity Multiplier2.07

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 6.50, provides a glimpse into top-line earnings distributed across each share. Net income per share, -2.78, reflects the portion of profit attributed to each share. The book value per share, 9.53, represents the net asset value distributed per share, while the tangible book value per share, 2.33, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share6.50
Net Income Per Share-2.78
Book Value Per Share9.53
Tangible Book Value Per Share2.33
Shareholders Equity Per Share9.53
Interest Debt Per Share8.23
Capex Per Share-0.42

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 11.26%, indicates top-line expansion, while the gross profit growth, 11.81%, reveals profitability trends. EBIT growth, -25.79%, and operating income growth, -25.79%, offer insights into operational profitability progression. The net income growth, -35.75%, showcases bottom-line expansion, and the EPS growth, -33.01%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth11.26%
Gross Profit Growth11.81%
EBIT Growth-25.79%
Operating Income Growth-25.79%
Net Income Growth-35.75%
EPS Growth-33.01%
EPS Diluted Growth-33.01%
Weighted Average Shares Growth2.08%
Weighted Average Shares Diluted Growth2.08%
Operating Cash Flow Growth-74.59%
Free Cash Flow Growth-23.14%
10-Year Revenue Growth per Share671.98%
5-Year Revenue Growth per Share25.47%
3-Year Revenue Growth per Share28.53%
10-Year Operating CF Growth per Share-123.05%
5-Year Operating CF Growth per Share-321.28%
3-Year Operating CF Growth per Share-130.83%
10-Year Net Income Growth per Share-447.43%
5-Year Net Income Growth per Share-651.45%
3-Year Net Income Growth per Share-2.80%
10-Year Shareholders Equity Growth per Share267.91%
5-Year Shareholders Equity Growth per Share91.95%
3-Year Shareholders Equity Growth per Share-36.44%
Receivables Growth10.47%
Inventory Growth10.95%
Asset Growth-6.18%
Book Value per Share Growth-14.65%
Debt Growth0.33%
R&D Expense Growth16.63%
SGA Expenses Growth16.14%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 4,140,210,170, captures the company's total value, considering both debt and equity. Income quality, 0.43, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.70, gauges operational efficiency, while the research and development to revenue, 45.68%, highlights investment in innovation. The ratio of intangibles to total assets, 37.12%, indicates the value of non-physical assets, and capex to operating cash flow, 35.06%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value4,140,210,170
Income Quality0.43
Sales General and Administrative to Revenue0.70
Research and Development to Revenue45.68%
Intangibles to Total Assets37.12%
Capex to Operating Cash Flow35.06%
Capex to Revenue-6.43%
Capex to Depreciation-53.32%
Stock-Based Compensation to Revenue13.83%
Graham Number24.42
Return on Tangible Assets-22.77%
Graham Net Net-2.73
Working Capital321,447,000
Tangible Asset Value112,676,000
Net Current Asset Value-83,187,000
Invested Capital1
Average Receivables37,961,500
Average Payables13,921,500
Average Inventory39,913,500
Days Sales Outstanding46
Days Payables Outstanding65
Days of Inventory On Hand203
ROIC-15.30%
ROE-0.29%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 11.84, and the price to book ratio, 11.84, reflect the market's valuation relative to the company's book value. The price to sales ratio, 16.61, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -72.11, and price to operating cash flows, -87.67, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio11.84
Price to Book Ratio11.84
Price to Sales Ratio16.61
Price Cash Flow Ratio-87.67
Enterprise Value Multiple-56.65
Price Fair Value11.84
Price to Operating Cash Flow Ratio-87.67
Price to Free Cash Flows Ratio-72.11
Price to Tangible Book Ratio8.34
Enterprise Value to Sales13.16
Enterprise Value Over EBITDA-50.42
EV to Operating Cash Flow-71.68
Earnings Yield-3.50%
Free Cash Flow Yield-2.03%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Glaukos Corporation (GKOS) on the NYSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -37.877 in 2024.

What is the ticker symbol of Glaukos Corporation stock?

The ticker symbol of Glaukos Corporation stock is GKOS.

What is company IPO date?

IPO date of Glaukos Corporation is 2015-06-25.

What is company current share price?

Current share price is 107.620 USD.

What is stock market cap today?

The market cap of stock today is 5420550350.000.

What is PEG ratio in 2024?

The current 0.000 is 0.000 in 2024.

What is the number of employees in 2024?

In 2024 the company has 907.